𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development and evaluation of a phenotypic assay monitoring resistance formation to protease inhibitors in HIV-1-infected patients

✍ Scribed by Heike Gehringer; Klaus Von der Helm; Sigrid Seelmeir; Benedikt Weißbrich; Josef Eberle; Hans Nitschko

Book ID
114140040
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
214 KB
Volume
109
Category
Article
ISSN
0166-0934

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Longitudinal use of phenotypic resistanc
Longitudinal use of phenotypic resistance testing to HIV-1 protease inhibitors in patients developing HAART failure
✍ Jean Servais; Jean-Marc Plesséria; Christine Lambert; Elodie Fontaine; Isabelle 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract An “in‐house” recombinant virus protease inhibitor susceptibility assay was carried out (median of 3 per patient) retrospectively in 26 patients failing HIV protease inhibitor based therapy at regular intervals to the initiation of the first protease inhibitor. Patients were treated wit

Long-term monitoring of genotypic and ph
Long-term monitoring of genotypic and phenotypic resistance to T20 in treated patients infected with HIV-1
✍ L. Pérez-Alvarez; R. Carmona; A. Ocampo; A. Asorey; C. Miralles; S. Pérez de Cas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

The aim of this study was to investigate the susceptibility to T20 and the dynamics of amino acid changes in HR1 and HR2 of gp41 of HIV-1 obtained from plasma, peripheral blood mononuclear cells (PBMC), and primary isolates (PI) in four highly antiretroviral-experienced patients. These patients rece

Development and significance of resistan
Development and significance of resistance to protease inhibitors in HIV-1-infected adults under triple-drug therapy in clinical practice
✍ Laura Romano; Giulietta Venturi; Saverio Giomi; Luigi Pippi; Pier E. Valensin; M 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

## Abstract Development of drug resistance is considered a major cause for failure of antiretroviral therapy in human immunodeficiency virus type 1 (HIV‐1)‐infected patients adherent to treatment. However, the rate of emergence and the significance of HIV‐1 drug resistance in clinical practice have

Diverse pattern of protease inhibitor re
Diverse pattern of protease inhibitor resistance mutations in HIV-1 infected patients failing nelfinavir
✍ Veronica Svedhem; A. Lindkvist; T. Bergroth; Lidman Knut; A. Sönnerborg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

## Abstract The aim of the study was to describe the pattern of resistance mutations in human immunodeficiency virus type 1 (HIV‐1) infected patients experiencing their first protease inhibitor (PI) failure on nelfinavir (NFV)‐containing therapy. Earlier PI‐naïve patients (n = 172) with NFV‐contain

Changes in the Vif protein of HIV-1 asso
Changes in the Vif protein of HIV-1 associated with the development of resistance to inhibitors of viral protease
✍ Melanie A. Adekale; Patricia A. Cane; Malcolm A. McCrae 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 621 KB

## Abstract The protease (__PR__) and virus infectivity factor (__vif__) gene sequences of a cohort of HIV‐1 infected patients showing evidence of developing protease inhibitor (PI) resistance whilst undergoing highly active antiretroviral therapy (HAART) have been determined. The PR sequences show